We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-15.01%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$461M
AUM Growth
-$222M
Cap. Flow
-$108M
Cap. Flow %
-23.46%
Top 10 Hldgs %
59.88%
Holding
143
New
25
Increased
20
Reduced
27
Closed
54

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$24.9M
2
VTRS icon
Viatris
VTRS
+$13.9M
3
ITRN icon
Ituran Location and Control
ITRN
+$8.4M
4
PFE icon
Pfizer
PFE
+$7.53M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.18M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$21.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$8.36M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.09M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.76M
5
INCY icon
Incyte
INCY
+$5.6M

Sector Composition

Rank Sector Weight
1 Healthcare 62.23%
2 Technology 3.77%
3 Utilities 2.89%
4 Communication Services 2.27%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
101
CALL
Alphabet (Google) Class C
GOOG
$4.36T
– –
-92,000
Closed -$3.58M
GOOG icon
102
Alphabet (Google) Class C
GOOG
$4.36T
– –
-148,180
Closed -$5.76M
HALO icon
103
Halozyme
HALO
$9.79B
– –
-135,000
Closed -$2.34M
HON icon
104
Honeywell
HON
$77B
– –
-28,485
Closed -$2.65M
INCY icon
105
Incyte
INCY
$24.2B
– –
-51,621
Closed -$5.6M
KALV
106
DELISTED
KalVista Pharmaceuticals
KALV
– –
-25,714
Closed -$1.3M
MA icon
107
Mastercard
MA
$506B
– –
-30,605
Closed -$2.98M
MDLZ icon
108
Mondelez International
MDLZ
$79.5B
– –
-68,625
Closed -$3.08M
NVAX icon
109
Novavax
NVAX
$1.2B
– –
-20,000
Closed -$3.36M
NVS icon
110
Novartis
NVS
$297B
– –
-20,088
Closed -$1.55M
NXPI icon
111
NXP Semiconductors
NXPI
$57.8B
– –
-16,920
Closed -$1.43M
OPK icon
112
Opko Health
OPK
$985M
– –
-500,000
Closed -$5.03M
PRQR icon
113
ProQR Therapeutics
PRQR
$243M
– –
-150,000
Closed -$1.3M
QURE icon
114
uniQure
QURE
$3.03B
– –
-153,500
Closed -$2.54M
SBUX icon
115
Starbucks
SBUX
$120B
– –
-46,828
Closed -$2.81M
SPY icon
116
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-400,000
Closed -$81.5M
TJX icon
117
TJX Companies
TJX
$174B
– –
-95,922
Closed -$3.4M
TVTX icon
118
Travere Therapeutics
TVTX
$5.2B
– –
-135,000
Closed -$2.6M
VRTX icon
119
Vertex Pharmaceuticals
VRTX
$121B
– –
-48,400
Closed -$6.09M
VTRS icon
120
CALL
Viatris
VTRS
$20.4B
– –
-300,000
Closed -$16.2M
WIX icon
121
WIX.com
WIX
$2.3B
– –
-35,460
Closed -$807K
XNTK icon
122
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
– –
-329,800
Closed -$23.2M
ATYR
123
aTyr Pharma
ATYR
$47.6M
– –
-2,604
Closed -$358K
TVRD
124
Tvardi Therapeutics
TVRD
$19.7M
– –
-5,495
Closed -$3.33M
ITCI
125
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-48,400
Closed -$2.6M
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sphera Funds Management held 143 positions worth $461M, down 32% from $683M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sphera Funds Management withdrew a net $108M in Q1 2016, closing 54 positions and reducing 27 holdings. Its most notable exit was AbbVie, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 61% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sphera Funds Management opened a new position in Viatris worth $13.3M.

  • Sphera Funds Management's largest Q1 2016 buy was Viatris: 287,827 shares worth $13.3M.
  • Sphera Funds Management added most to Shire pic in Q1 2016, an estimated $24.9M increase.
  • Sphera Funds Management's biggest Q1 2016 reduction was Celgene Corp, cutting an estimated $4.86M.
  • Sphera Funds Management fully exited AbbVie in Q1 2016, selling an estimated $21.4M.
  • Sphera Funds Management's ten largest holdings make up 60% of its $461M portfolio in Q1 2016.
  • Sphera Funds Management opened 25 new positions and closed 54 in Q1 2016.
  • Sphera Funds Management's portfolio value fell 32% quarter-over-quarter to $461M.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.